NewzAccording to new clinical trial results released on Tuesday, October 13, 2026, an experimental artificial cataract lens has been shown to potentially help treat glaucoma in patients. The specialized lens is designed to deliver medication through small built-in pads with a sustained-release mechanism.
The development combines the standard treatment for cataracts with targeted pharmaceutical intervention for glaucoma. By utilizing sustained-release medication directly within the artificial lens, the technology aims to simplify therapeutic management for individuals suffering from both conditions.
In-depth summary · AI, neutral